189 related articles for article (PubMed ID: 26612043)
1. Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling.
Zhang Y; Wei Z; Li J; Liu P
Sci China Life Sci; 2015 Dec; 58(12):1246-55. PubMed ID: 26612043
[TBL] [Abstract][Full Text] [Related]
2. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
3. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ
Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640
[TBL] [Abstract][Full Text] [Related]
5. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
[TBL] [Abstract][Full Text] [Related]
6. Update on MALT lymphomas.
Isaacson PG
Best Pract Res Clin Haematol; 2005 Mar; 18(1):57-68. PubMed ID: 15694184
[TBL] [Abstract][Full Text] [Related]
7. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of MALT lymphomas: where do we stand?
Sagaert X; De Wolf-Peeters C; Noels H; Baens M
Leukemia; 2007 Mar; 21(3):389-96. PubMed ID: 17230229
[TBL] [Abstract][Full Text] [Related]
9. The t(14;18)(q32;q21)/IGH-MALT1 translocation in gastrointestinal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Zhang S; Wei M; Liang Q; Johnson D; Dow N; Nelson A; Aguilera N; Auerbach A; Wang G
Histopathology; 2014 May; 64(6):791-8. PubMed ID: 24236896
[TBL] [Abstract][Full Text] [Related]
10. Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance.
Inagaki H
Pathol Int; 2007 Aug; 57(8):474-84. PubMed ID: 17610471
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma.
Farinha P; Gascoyne RD
J Clin Oncol; 2005 Sep; 23(26):6370-8. PubMed ID: 16155022
[TBL] [Abstract][Full Text] [Related]
12. MALT lymphoma: A paradigm of NF-κB dysregulation.
Du MQ
Semin Cancer Biol; 2016 Aug; 39():49-60. PubMed ID: 27452667
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.
Nakagawa M; Seto M; Hosokawa Y
Leukemia; 2006 Jun; 20(6):929-36. PubMed ID: 16572204
[TBL] [Abstract][Full Text] [Related]
14. MALT lymphoma: many roads lead to nuclear factor-κb activation.
Du MQ
Histopathology; 2011 Jan; 58(1):26-38. PubMed ID: 21261681
[TBL] [Abstract][Full Text] [Related]
15. MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism.
Du MQ
Best Pract Res Clin Haematol; 2017; 30(1-2):13-23. PubMed ID: 28288707
[TBL] [Abstract][Full Text] [Related]
16. Gastric lymphomas: genetics and resistance to H. pylori eradication.
Isaacson PG; Du MQ
Verh Dtsch Ges Pathol; 2003; 87():116-22. PubMed ID: 16888902
[TBL] [Abstract][Full Text] [Related]
17. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
Rosebeck S; Lucas PC; McAllister-Lucas LM
Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma.
Kuo SH; Weng WH; Chen ZH; Hsu PN; Wu MS; Lin CW; Jeng HJ; Yeh KH; Tsai HJ; Chen LT; Cheng AL
Genes Chromosomes Cancer; 2011 Nov; 50(11):908-21. PubMed ID: 21837708
[TBL] [Abstract][Full Text] [Related]
19. t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
Kuo SH; Cheng AL; Lin CW; Hsu CH; Wu MS; Yeh KH; Tzeng YS; Chen LT
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1387-95. PubMed ID: 21465313
[TBL] [Abstract][Full Text] [Related]
20. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
